CooperVision® Further Expands Parameters for MyDay® toric Contact Lenses
MyDay® toric Range Will Match Biofinity® toric to Provide More Prescription Options
Sydney Australia, March 27, 2023 — CooperVision—a global leader in toric contact lenses 1.—has announced its latest parameter expansion for MyDay® toric, increasing its current range by nearly 70% to 4392 prescription options. With the additional options, MyDay® toric now matches the industry-leading range of Biofinity® toric 2. to enable Optometrists to fit the vast majority of their astigmatic patients with a silicone hydrogel 1-day lens. 3. The full range will be available across Australia and New Zealand from 20th March.
“We appreciate that optometrists want to be able to prescribe the best lens for each patient and not be limited by restrictions in the available parameters. For years, Biofinity® toric has set the standard for toric contact lenses, 4. and optometrists have found tremendous utility from its comprehensive parameter range. This same range is now available with MyDay® toric, ending the need for practitioners to prescribe a monthly lens when a daily disposable may be preferred,” said Joe Tanner, Professional Services Manager at CooperVision.
MyDay® toric will be available in the following prescription options:
CooperVision’s MyDay® toric lenses combine the proven design features of Biofinity® toric with the premium silicone hydrogel 1-day material of MyDay®. Its outstanding toric technology, Optimised Toric Lens Geometry™, provides uniform horizontal iso-thickness, a large toric optic zone, a smooth, continuous ballast and an optimised ballast toric design for a predictable, stable and comfortable fit.
In addition, the MyDay® family of lenses features Aquaform® Technology, which provides a unique combination of high oxygen permeability, a naturally wettable material, and optimum modulus for increased breathability and moisture in a soft, flexible lens. The material and design also provide for easy lens handling and there is a UV inhibitor which filters 86% of UVA and 97% of UVB rays*.
To help streamline the fitting process and minimise chair time, CooperVision also offers the OptiExpert™ fitting app. 5. The easy-to-use app includes a calculator which determines the recommended diagnostic lenses. A desktop version is also available.
For more information about MyDay® toric, visit MyDay® daily disposable toric | CooperVision Australia.
About CooperVision
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com
About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries.
For more information, please visit www.coopercos.com
Media Contact Shannon Morrow, CooperVision ANZ smorrow@au.coopervision.com or 0437 866 918
1. CooperVision data on file 2020. Kubic Online Survey of ECPs in US, Germany, Spain, Japan and South Korea. Total weighted sample = 549.
2. CooperVision data on file 2021. Rx coverage database; 14 to 70 years.
3. CooperVision data on file 2021; Rx coverage database n=83,540 eyes; 14 to 70 years; coverage for 95%.
4. CooperVision data on file, 2020. Kubic Online Survey of ECPs in US, Germany, Spain, Japan and South Korea. Total weighted sample n = 549. Significantly higher than toric lens brands from Johnson & Johnson Vision, Alcon and Bausch + Lomb; p<0.05.
5. Luensmann D et al. Toric lens fitting success supported by an online fitting App. Poster to be presented at NCC/BCLA 2020.
*Warning: UV-absorbing contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. Patients should continue to use UVabsorbing eyewear as directed
PO Box 134, Marleston SA 5033, AUSTRALIA
ABN 12 060 200 553
AU 1800 655 480
Email info@au.coopervision.com
NZ 0800 60 60 60
Email sales@coopervision.co.nz